ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling.

Jie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.